A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More

A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More
A groundbreaking study published in Science Advances reveals that researchers in China have successfully engineered eye drops utilizing exosomes derived…
Read More
Acute myelogenous leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…
Read More
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
In a landmark study that promises to redefine the landscape of musculoskeletal medicine, researchers at the Institute of Science Tokyo…
Read More
MSD (Merck & Co) has achieved a significant milestone in the fight against Human Immunodeficiency Virus (HIV) with the U.S.…
Read More
The realm of neural interfaces, critical for understanding and treating a myriad of neurological conditions, has long grappled with a…
Read More
The treatment paradigm for locally advanced head and neck squamous cell carcinoma (LA HNSCC) is undergoing a significant transformation, driven…
Read More
Researchers at Michigan State University (MSU) have identified a critical molecular "switch" that triggers a massive surge in sperm energy…
Read More
Acute Myelogenous Leukemia (AML) has long remained one of the most formidable challenges in oncology, characterized by its rapid progression…
Read More